(Q37756172)

22 August 2017

1 reference

title

Single-cell network profiling (SCNP) by flow cytometry in autoimmune disease (English)

1 reference

22 August 2017

1 reference

1 reference

Todd M Covey

1

1 reference

22 August 2017

Alessandra Cesano

series ordinal

2

1 reference

22 August 2017

David R Parkinson

series ordinal

3

1 reference

22 August 2017

publication date

1 November 2010

1 reference

22 August 2017

1 reference

22 August 2017

volume

43

1 reference

22 August 2017

issue

7

1 reference

22 August 2017

page(s)

550-559

1 reference

describes a project that uses

22 August 2017

1 reference

Biological therapies: a novel approach to the treatment of autoimmune disease

1 reference

https://api.crossref.org/works/10.3109%2F08916931003674774

Biologic therapies in clinical development for the treatment of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916931003674774

Emerging biologic drugs for the treatment of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916931003674774

Molecular targets in immune-mediated diseases: focus on rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916931003674774

The challenge of multiple sclerosis: how do we cure a chronic heterogeneous disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916931003674774

Myasthenia gravis with anti-acetylcholine receptor antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916931003674774

Multiple sclerosis: a complicated picture of autoimmunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916931003674774

Analysis of protein phosphorylation and cellular signaling events by flow cytometry: techniques and clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916931003674774

What's wrong with drug screening today

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916931003674774

Kinetics of B cell receptor signaling in human B cell subsets mapped by phosphospecific flow cytometry

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916931003674774

Altered B cell receptor signaling in human systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916931003674774

Tyrosine kinases as targets for the treatment of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916931003674774

Stage dependent aberrant regulation of cytokine-STAT signaling in murine systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916931003674774

B cells from patients with systemic lupus erythematosus display abnormal antigen receptor-mediated early signal transduction events

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916931003674774

The emerging role of interferon in human systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916931003674774

Flow cytometric assessment of the signaling status of human B lymphocytes from normal and autoimmune individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916931003674774

Multiparameter phospho-flow analysis of lymphocytes in early rheumatoid arthritis: implications for diagnosis and monitoring drug therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916931003674774

Single cell profiling of potentiated phospho-protein networks in cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916931003674774

Single-cell profiling identifies aberrant STAT5 activation in myeloid malignancies with specific clinical and biologic correlates

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916931003674774

Distinct signaling mechanisms activate the target of rapamycin in response to different B-cell stimuli.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916931003674774

Measuring phosphorylated Akt and other phosphoinositide 3-kinase-regulated phosphoproteins in primary lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916931003674774

High-content single-cell drug screening with phosphospecific flow cytometry

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916931003674774

A novel CCR5-specific pharmacodynamic assay in whole blood using phosphoflow cytometry highlights different ligand-dependent responses but similar properties of antagonists in CD8+ and CD4+ T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916931003674774

Measurement of MAP kinase activation by flow cytometry using phospho-specific antibodies to MEK and ERK: potential for pharmacodynamic monitoring of signal transduction inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916931003674774

Flow cytometry for high-throughput, high-content screening

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916931003674774

Fluorescent cell barcoding in flow cytometry allows high-throughput drug screening and signaling profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916931003674774

Evaluation of an orthogonal pooling strategy for rapid high-throughput screening of proteases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916931003674774

The T cell STAT signaling network is reprogrammed within hours of bacteremia via secondary signals

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916931003674774

Development and validation of a drug activity biomarker that shows target inhibition in cancer patients receiving enzastaurin, a novel protein kinase C-beta inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916931003674774

Pharmacodynamic monitoring of BAY 43-9006 (Sorafenib) in phase I clinical trials involving solid tumor and AML/MDS patients, using flow cytometry to monitor activation of the ERK pathway in peripheral blood cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916931003674774

Pharmacodynamic monitoring of molecular-targeted agents in the peripheral blood of leukemia patients using flow cytometry

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916931003674774

10.3109/08916931003674774

21 January 2018

Identifiers

DOI

1 reference

22 August 2017

1 reference